The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Activation, coactivation, and costimulation of resting human natural killer cells
Open accessAbstract
Summary: Natural killer (NK) cells possess potent perforin‐ and interferon‐γ‐dependent effector functions that are tightly regulated. Inhibitory receptors for major histocompatibility complex class I display variegated expression among NK cells, which confers specificity to individual NK cells. Specificity is also provided by engagement of an array of NK cell activation receptors. Target cells may express ligands for a multitude of activation receptors, many of which signal through different pathways. How inhibitory receptors intersect different signaling cascades is not fully understood. This review focuses on advances in understanding how activation receptors cooperate to induce cytotoxicity in resting NK cells. The role of activating receptors in determining specificity and providing redundancy of target cell recognition is discussed. Using Drosophila insect cells as targets, we have examined the contribution of individual receptors. Interestingly, the strength of activation is not determined simply by additive effects of parallel activation pathways. Combinations of signals from different receptors can have different outcomes: synergy, no enhancement over individual signals, or additive effects. Cytotoxicity requires combined signals for granule polarization and degranulation. The integrin leukocyte function‐associated antigen‐1 contributes a signal for polarization but not for degranulation. Conversely, CD16 alone or in synergistic combinations, such as NKG2D and 2B4, signals for phospholipase‐C‐γ‐ and phosphatidylinositol‐3‐kinase‐dependent degranulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 1×
“The ‘missing-self’ hypothesis (24) advocates a role for NK cell inhibitory receptors and target cell MHC class I expression in determining NK cell specificity.”
BackgroundSelf-citationDustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Functional significance of the perforin/granzyme cell death pathway
Trapani, J. A., & Smyth, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri911 · Cited by 1,291
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 875
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
Self-citationFehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 857
Bidirectional Transmembrane Signaling by Cytoplasmic Domain Separation in Integrins
Kim, M., Carman, C. V., & Springer, T. A. (2003) · Science · doi:10.1126/science.1084174 · Cited by 786
Natural Killer Cell Signaling Pathways
Vivier, E., Nunès, J. A., & Vély, F. (2004) · Science · doi:10.1126/science.1103478 · Cited by 751
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., & Hsu, M.-L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80529-4 · Cited by 695
O'Shea, J. J., Ma, A., & Lipsky, P. (2002) · Nature Reviews Immunology · doi:10.1038/nri702 · Cited by 675
Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G. (2000) · Science · doi:10.1126/science.287.5455.1031 · Cited by 661
Anderson, D. C., Schmalsteig, F. C., Finegold, M. J., Hughes, B. J., Rothlein, R., Miller, L. J., Kohl, S., Tosi, M. F., Jacobs, R. L., Waldrop, T. C., et al. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.4.668 · Cited by 634
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., & Long, E. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80300-3 · Cited by 613
Self-citationFerlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1455 · Cited by 589
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Krensky, A. M., Sanchez-Madrid, F., Robbins, E., Nagy, J. A., Springer, T. A., & Burakoff, S. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.611 · Cited by 571
Calpain-mediated proteolysis of talin regulates adhesion dynamics
Franco, S. J., Rodgers, M. A., Perrin, B. J., Han, J., Bennin, D. A., Critchley, D. R., & Huttenlocher, A. (2004) · Nature Cell Biology · doi:10.1038/ncb1175 · Cited by 561
Arnould, L., Gelly, M., Penault-Llorca, F., Benoit, L., Bonnetain, F., Migeon, C., Cabaret, V, Fermeaux, V, Bertheau, P., Garnier, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602930 · Cited by 545
Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H.-G., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051143 · Cited by 515
Self-citationMHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Intracellular signalling controlling integrin activation in lymphocytes
Kinashi, T. (2005) · Nature Reviews Immunology · doi:10.1038/nri1646 · Cited by 477
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Phospholipase Cγ2 Is Essential in the Functions of B Cell and Several Fc Receptors
Wang, D., Feng, J., Wen, R., Marine, J.-C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L., Murray, P. J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00005-4 · Cited by 475
CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells
Jacobs, R., Hintzen, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K.-W., & Schmidt, R. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3121::aid-immu3121>3.0.co;2-4 · Cited by 475
Katagiri, K., Maeda, A., Shimonaka, M., & Kinashi, T. (2003) · Nature Immunology · doi:10.1038/ni950 · Cited by 461
Rituximab-Dependent Cytotoxicity by Natural Killer Cells
Dall’Ozzo, S., Tartas, S., Paintaud, G., Cartron, G., Colombat, P., Bardos, P., Watier, H., & Thibault, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2862 · Cited by 434
The Molecular Basis of Filamin Binding to Integrins and Competition with Talin
Kiema, T., Lad, Y., Jiang, P., Oxley, C. L., Baldassarre, M., Wegener, K. L., Campbell, I. D., Ylänne, J., & Calderwood, D. A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.011 · Cited by 434
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L., & Yokoyama, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050588297 · Cited by 424
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
Dorman, S. E., Picard, C., Lammas, D., Heyne, K., van Dissel, J. T., Baretto, R., Rosenzweig, S. D., Newport, M., Levin, M., Roesler, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17552-1 · Cited by 422
2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A., & Neil Barclay, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2083 · Cited by 415
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
Jegerlehner, A., Schmitz, N., Storni, T., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5598 · Cited by 397
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., et al. (2005) · Nature Immunology · doi:10.1038/ni1190 · Cited by 397
Dendritic cell maturation by innate lymphocytes
Münz, C., Steinman, R. M., & Fujii, S.-I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050810 · Cited by 393
NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Chapman, T. L., Heikema, A. P., & Bjorkman, P. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80135-1 · Cited by 366
The Structure of a Human Type III Fcγ Receptor in Complex with Fc
Radaev, S., Motyka, S., Fridman, W.-H., Sautes-Fridman, C., & Sun, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100350200 · Cited by 354
Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., Meer, A. V. D., Joosten, I., & Long, E. O. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040009 · Cited by 353
Self-citationVoehringer, D., Koschella, M., & Pircher, H. (2002) · Blood · doi:10.1182/blood-2002-02-0657 · Cited by 352
Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells
Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Hong-Geller, E., Wei, S., & Djeu, J. Y. (2000) · Nature Immunology · doi:10.1038/80859 · Cited by 347
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Protein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Binstadt, B. A., Brumbaugh, K. M., Dick, C. J., Scharenberg, A. M., Williams, B. L., Colonna, M., Lanier, L. L., Kinet, J.-P., Abraham, R. T., & Leibson, P. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80276-9 · Cited by 338
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
LFA-1 Contributes an Early Signal for NK Cell Cytotoxicity
Barber, D. F., Faure, M., & Long, E. O. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3653 · Cited by 321
Self-citationStewart, M. P., McDowall, A., & Hogg, N. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.699 · Cited by 319
Kupfer, A., Dennert, G., & Singer, S. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.23.7224 · Cited by 307
Nishida, K., Yamasaki, S., Ito, Y., Kabu, K., Hattori, K., Tezuka, T., Nishizumi, H., Kitamura, D., Goitsuka, R., Geha, R. S., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501111 · Cited by 307
A human lymphocyte‐associated antigen involved in cell‐mediated lympholysis
Hildreth, J. E. K., Gotch, F. M., Hildreth, P. D. K., & McMichael, A. J. (1983) · European Journal of Immunology · doi:10.1002/eji.1830130305 · Cited by 305
Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2006) · Nature Immunology · doi:10.1038/ni1325 · Cited by 300
Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
Lanier, L. L., Ruitenberg, J. J., & Phillips, J. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.10.3478 · Cited by 299
Kupfer, A. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.309 · Cited by 296
Comparative Genomics of Natural Killer Cell Receptor Gene Clusters
Kelley, J., Walter, L., & Trowsdale, J. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010027 · Cited by 290
Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor
Rosen, D. B., Bettadapura, J., Alsharifi, M., Mathew, P. A., Warren, H. S., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7796 · Cited by 288
Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor
Aldemir, H., Prod’homme, V., Dumaurier, M.-J., Retiere, C., Poupon, G., Cazareth, J., Bihl, F., & Braud, V. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7791 · Cited by 285
Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans
Khakoo, S. I., Rajalingam, R., Shum, B. P., Weidenbach, K., Flodin, L., Muir, D. G., Canavez, F., Cooper, S. L., Valiante, N. M., Lanier, L. L., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80219-8 · Cited by 277
Höglund, P., Ohlén, C., Carbone, E., Franksson, L., Ljunggren, H. G., Latour, A., Koller, B., & Kärre, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10332 · Cited by 271
Self-citationDownregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141
Tomasec, P., Wang, E. C. Y., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P., Morris, R. J., Llewellyn-Lacey, S., Rickards, C., et al. (2005) · Nature Immunology · doi:10.1038/ni1156 · Cited by 271
Iizuka, K., Naidenko, O. V., Plougastel, B. F. M., Fremont, D. H., & Yokoyama, W. M. (2003) · Nature Immunology · doi:10.1038/ni954 · Cited by 270
KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential
Faure, M., & Long, E. O. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6208 · Cited by 268
Self-citationIshido, S., Choi, J.-K., Lee, B.-S., Wang, C., DeMaria, M., Johnson, R. P., Cohen, G. B., & Jung, J. U. (2000) · Immunity · doi:10.1016/s1074-7613(00)00036-4 · Cited by 262
Physical and Functional Association of LFA-1 with DNAM-1 Adhesion Molecule
Shibuya, K., Lanier, L. L., Phillips, J. H., Ochs, H. D., Shimizu, K., Nakayama, E., Nakauchi, H., & Shibuya, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80136-3 · Cited by 260
Ito, M., Maruyama, T., Saito, N., Koganei, S., Yamamoto, K., & Matsumoto, N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051986 · Cited by 260
Rajagopalan, S., Fu, J., & Long, E. O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1877 · Cited by 258
Self-citationCellular ligands of activating NK receptors
Bottino, C., Castriconi, R., Moretta, L., & Moretta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.02.007 · Cited by 255
Nicoll, G., Ni, J., Liu, D., Klenerman, P., Munday, J., Dubock, S., Mattei, M.-G., & Crocker, P. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34089 · Cited by 253
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A., Bloushtain, N., Lev, M., Joseph, A., et al. (2004) · Blood · doi:10.1182/blood-2003-05-1716 · Cited by 253
Stebbins, C. C., Watzl, C., Billadeau, D. D., Leibson, P. J., Burshtyn, D. N., & Long, E. O. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6291-6299.2003 · Cited by 245
Self-citationArousal and inhibition of human NK cells
Lanier, L. L., Corliss, B., & Phillips, J. H. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00947.x · Cited by 243
Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death
Pace, K. E., Hahn, H. P., Pang, M., Nguyen, J. T., & Baum, L. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2331 · Cited by 231
Zhang, J. Q., Nicoll, G., Jones, C., & Crocker, P. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002788200 · Cited by 229
Kaiser, B. K., Barahmand-pour, F., Paulsene, W., Medley, S., Geraghty, D. E., & Strong, R. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2878 · Cited by 229
Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
Valiante, N. M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1397 · Cited by 223
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
Eissmann, P., Beauchamp, L., Wooters, J., Tilton, J. C., Long, E. O., & Watzl, C. (2005) · Blood · doi:10.1182/blood-2004-09-3796 · Cited by 211
Self-citationMissing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors
Carlyle, J. R., Jamieson, A. M., Gasser, S., Clingan, C. S., Arase, H., & Raulet, D. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308304101 · Cited by 211
Abi-Rached, L., & Parham, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042558 · Cited by 211
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., & Kumar, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031989 · Cited by 208
How Do Natural Killer Cells Find Self to Achieve Tolerance?
Yokoyama, W. M., & Kim, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.006 · Cited by 206
Bouchon, A., Cella, M., Grierson, H. L., Cohen, J. I., & Colonna, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5517 · Cited by 198
Sivori, S., Falco, M., Marcenaro, E., Parolini, S., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072065999 · Cited by 195
Missing self recognition and self tolerance of natural killer (NK) cells
Raulet, D. H. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.003 · Cited by 195
Igarashi, T., Wynberg, J., Srinivasan, R., Becknell, B., McCoy, J. P., Takahashi, Y., Suffredini, D. A., Linehan, W. M., Caligiuri, M. A., & Childs, R. W. (2004) · Blood · doi:10.1182/blood-2003-12-4438 · Cited by 195
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214843 · Cited by 195
Bunting, M., Harris, E. S., McIntyre, T. M., Prescott, S. M., & Zimmerman, G. A. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200201000-00006 · Cited by 193
ITAMs versus ITIMs: striking a balance during cell regulation
Billadeau, D. D., & Leibson, P. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14843 · Cited by 192
NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases
Zompi, S., Hamerman, J. A., Ogasawara, K., Schweighoffer, E., Tybulewicz, V. L. J., Di Santo, J. P., Lanier, L. L., & Colucci, F. (2003) · Nature Immunology · doi:10.1038/ni930 · Cited by 189
Natural killer cells determine the outcome of B cell–mediated autoimmunity
Shi, F.-D., Wang, H.-B., Li, H., Hong, S., Taniguchi, M., Link, H., Kaer, L. V., & Ljunggren, H.-G. (2000) · Nature Immunology · doi:10.1038/79792 · Cited by 187
Self-citationThe Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated Killing
Billadeau, D. D., Brumbaugh, K. M., Dick, C. J., Schoon, R. A., Bustelo, X. R., & Leibson, P. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.549 · Cited by 182
Mechanisms contributing to the activity of integrins on leukocytes
Hogg, N., Henderson, R., Leitinger, B., McDowall, A., Porter, J., & Stanley, P. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18614.x · Cited by 180
Anikeeva, N., Somersalo, K., Sims, T. N., Thomas, V. K., Dustin, M. L., & Sykulev, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502467102 · Cited by 179
The DNA Damage Response Arouses the Immune System
Gasser, S., & Raulet, D. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4603 · Cited by 178
Avril, T., Floyd, H., Lopez, F., Vivier, E., & Crocker, P. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6841 · Cited by 175
Wang, J., & Springer, T. A. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01198.x · Cited by 171
Gründemann, C., Bauer, M., Schweier, O., von Oppen, N., Lässing, U., Saudan, P., Becker, K.-F., Karp, K., Hanke, T., Bachmann, M. F., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1311 · Cited by 169
NKG2D ligands: unconventional MHC class I‐like molecules exploited by viruses and cancer
Cerwenka, A., & Lanier, L. L. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00070.x · Cited by 167
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma
Gluck, W. L., Hurst, D., Yuen, A., Levine, A. M., Dayton, M. A., Gockerman, J. P., Lucas, J., Denis-Mize, K., Tong, B., Navis, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1087-3 · Cited by 166
Natural Killer Cells Produce T Cell–Recruiting Chemokines in Response to Antibody-Coated Tumor Cells
Roda, J. M., Parihar, R., Magro, C., Nuovo, G. J., Tridandapani, S., & Carson, W. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2429 · Cited by 165
Johansson, S., Johansson, M., Rosmaraki, E., Vahlne, G., Mehr, R., Salmon-Divon, M., Lemonnier, F., Kärre, K., & Höglund, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050167 · Cited by 164
Alloreactive killer cells: hindrance and help for haematopoietic transplants
Parham, P., & McQueen, K. (2003) · Nature reviews. Immunology · doi:10.1038/nri999 · Cited by 162
Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor
Roncagalli, R., Taylor, J. E. R., Zhang, S., Shi, X., Chen, R., Cruz-Munoz, M.-E., Yin, L., Latour, S., & Veillette, A. (2005) · Nature Immunology · doi:10.1038/ni1242 · Cited by 160
Kikuchi-Maki, A., Catina, T. L., & Campbell, K. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3859 · Cited by 157
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
André, P., Castriconi, R., Espéli, M., Anfossi, N., Juarez, T., Hüe, S., Conway, H., Romagné, F., Dondero, A., Nanni, M., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324705 · Cited by 157
Storkus, W. J., & Dawson, J. R. (1991) · PubMed · Cited by 154
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · Cited by 153
Riteau, B., Barber, D. F., & Long, E. O. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021995 · Cited by 151
Self-citationvon Strandmann, E. P., Hansen, H. P., Reiners, K. S., Schnell, R., Borchmann, P., Merkert, S., Simhadri, V. R., Draube, A., Reiser, M., Purr, I., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2177 · Cited by 147
Inhibition of Immune Responses by ITAM-Bearing Receptors
Hamerman, J. A., & Lanier, L. L. (2006) · Science s STKE · doi:10.1126/stke.3202006re1 · Cited by 143
Caraux, A., Kim, N., Bell, S. E., Zompi, S., Ranson, T., Lesjean-Pottier, S., Garcia-Ojeda, M. E., Turner, M., & Colucci, F. (2006) · Blood · doi:10.1182/blood-2005-06-2428 · Cited by 142
Jackson, M. R., Song, E. S., Yang, Y. M., & Peterson, P. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12117 · Cited by 141
Immunogenetics of viral infections.
Martin, M. P., & Carrington, M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.012 · Cited by 141
Zimmer, J., Donato, L., Hanau, D., Cazenave, J., Tongio, M., Moretta, A., & de la Salle, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.117 · Cited by 139
Expression and function of CD7 molecule on human natural killer cells.
Rabinowich, H., Pricop, L., Herberman, R. B., & Whiteside, T. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.517 · Cited by 137
CTL secretory lysosomes: biogenesis and secretion of a harmful organelle
Bossi, G., & Griffiths, G. M. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.09.007 · Cited by 133
da Silva, A. J., Brickelmaier, M., Majeau, G. R., Li, Z., Su, L., Hsu, Y., & Hochman, P. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4462 · Cited by 132
Preithner, S., Elm, S., Lippold, S., Locher, M., Wolf, A., da Silva, A. J., Baeuerle, P. A., & Prang, N. S. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.010 · Cited by 131
Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases
Colucci, F., Schweighoffer, E., Tomasello, E., Turner, M., Ortaldo, J. R., Vivier, É., Tybulewicz, V. L. J., & Santo, J. P. D. (2002) · Nature Immunology · doi:10.1038/ni764 · Cited by 130
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.
Ruggeri, L., Mancusi, A., Capanni, M., Martelli, M., & Velardi, A. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.007 · Cited by 128
Wülfing, C., Purtic, B., Klem, J., & Schatzle, J. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1336920100 · Cited by 123
Differential Requirements for Vav Proteins in DAP10- and ITAM-mediated NK Cell Cytotoxicity
Cella, M., Fujikawa, K., Tassi, I., Kim, S., Latinis, K. M., Nishi, S., Yokoyama, W. M., Colonna, M., & Swat, W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031847 · Cited by 122
Phospholipase C-γ2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors
Tassi, I., Presti, R., Kim, S., Yokoyama, W. M., Gilfillan, S., & Colonna, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.749 · Cited by 121
Barakonyi, A., Rabot, M., Marie‐Cardine, A., Aguerre‐Girr, M., Polgár, B., Schiavon, V., Bensussan, A., & Bouteiller, P. P. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5349 · Cited by 120
Role of natural killer cells in innate resistance to protozoan infections
Scharton‐Kersten, T., & Sher, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80157-4 · Cited by 119
Chen, R., Relouzat, F., Roncagalli, R., Aoukaty, A., Tan, R., Latour, S., & Veillette, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5144-5156.2004 · Cited by 117
The role of IL-12, IL-23 and IFN-γ in immunity to viruses
Novelli, F., & Casanova, J. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.009 · Cited by 117
Fagerholm, S. C., Hilden, T. J., Nurmi, S. M., & Gahmberg, C. G. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504016 · Cited by 112
Miedema, F. F., Tetteroo, P. A. T., Hesselink, W. G., Werner, G., Spits, H., & Melief, C. J. M. (1984) · European Journal of Immunology · doi:10.1002/eji.1830140607 · Cited by 111
Tkaczyk, C., Beaven, M. A., Brachman, S. M., Metcalfe, D. D., & Gilfillan, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301350200 · Cited by 106
Barber, D. F., & Long, E. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.294 · Cited by 105
Self-citationWatzl, C., Stebbins, C. C., & Long, E. O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3545 · Cited by 102
Self-citationOn the species specificity of the interaction of LFA-1 with intercellular adhesion molecules.
Johnston, S. C., Dustin, M. L., Hibbs, M. L., & Springer, T. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.4.1181 · Cited by 101
Mainiero, F., Soriani, A., Strippoli, R., Jacobelli, J., Gismondi, A., Piccoli, M., Frati, L., & Santoni, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80154-5 · Cited by 100
Multiplicity and plasticity of natural killer cell signaling pathways
Chiesa, S., Mingueneau, M., Fuséri, N., MALISSEN, B., Raulet, D. H., Malissen, M., Vivier, É., & Tomasello, E. (2005) · Blood · doi:10.1182/blood-2005-08-3504 · Cited by 99
Altered natural killer cell repertoire in Tap-1 mutant mice.
Ljunggren, H., Kaer, L. V., Ploegh, H. L., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6520 · Cited by 97
Self-citationShibuya, A., Lanier, L. L., & Phillips, J. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1671 · Cited by 96
Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin
Gismondi, A., Morrone, S., Humphries, M. J., Piccoli, M., Frati, L., & Santoni, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.384 · Cited by 95
Dendritic Cell-NK Cell Cross-Talk: Regulation and Physiopathology
Zitvogel, L., Terme, M., Borg, C., & Trinchieri, G. (2005) · Springer eBooks · doi:10.1007/3-540-27743-9_8 · Cited by 94
Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.
Bottino, C., Moretta, L., Pende, D., Vitale, M., & Moretta, A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.004 · Cited by 88
The role of natural killer cells in tumor control—effectors and regulators of adaptive immunity
Wallace, M. E., & Smyth, M. J. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0195-x · Cited by 88
Rose, D. M., Liu, S., Woodside, D. G., Han, J., Schlaepfer, D. D., & Ginsberg, M. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.5912 · Cited by 87
Fischer, L., Penack, O., Gentilini, C., Nogai, A., Muessig, A., Thiel, E., & Uharek, L. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.015 · Cited by 87
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. A. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.7.2231 · Cited by 87
Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction
Flaig, R. M., Stark, S., & Watzl, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6524 · Cited by 86
Matsumoto, G., Nghiem, M. P., Nozaki, N., Schmits, R., & Penninger, J. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5781 · Cited by 83
Fc Receptors on Natural Killer Cells
PERUSSIA, B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_6 · Cited by 79
Gismondi, A., Bisogno, L., Mainiero, F., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4729 · Cited by 72
Sánchez-Martín, L., Sánchez‐Sánchez, N., Gutiérrez‐López, M. D., Rojo, A. I., Vicente‐Manzanares, M., Pérez-Álvarez, M. J., Sánchez‐Mateos, P., Bustelo, X. R., Cuadrado, A., Sánchez‐Madrid, F., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400905200 · Cited by 72
The Isoforms of Phospholipase C-γ Are Differentially Used by Distinct Human NK Activating Receptors
Upshaw, J. L., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.213 · Cited by 70
Butcher, S., Arney, K. L., & Cook, G. P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3755::aid-immu3755>3.0.co;2-3 · Cited by 68
P marks the spot: site-specific integrin phosphorylation regulates molecular interactions
Fagerholm, S. C., Hilden, T. J., & Gahmberg, C. G. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.07.005 · Cited by 65
T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase
Huang, J., Tilly, D. A., Altman, A., Sugie, K., & Grey, H. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10923 · Cited by 64
Faure, M., Barber, D. F., Takahashi, S. M., Jin, T., & Long, E. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6107 · Cited by 62
Self-citationGismondi, A., Jacobelli, J., Strippoli, R., Mainiero, F., Soriani, A., Cifaldi, L., Piccoli, M., Frati, L., & Santoni, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3065 · Cited by 60
Perez, O. D., Mitchell, D. J., Jager, G. C., & Nolan, G. P. (2004) · Blood · doi:10.1182/blood-2003-08-2652 · Cited by 59
Identification of CD7 as a Cognate of the Human K12 (SECTM1) Protein
Lyman, S. D., Escobar, S. M., Rousseau, A.-M., Armstrong, A. J., & Fanslow, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3431 · Cited by 49
Liu, D., Xu, L., Yang, F., Li, D., Gong, F., & Xu, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405737102 · Cited by 46
Ting, A. T., Schoon, R. A., Abraham, R. T., & Leibson, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35930-1 · Cited by 40
Anatomy of a murder—signal transduction pathways leading to activation of natural killer cells
Zompì, S., & Colucci, F. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.10.006 · Cited by 36
Milella, M., Gismondi, A., Roncaioli, P., et al. (1999) · PubMed · Cited by 29
Milella, M., Gismondi, A., Roncaioli, P., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2064 · Cited by 22
Hildreth, J. E. K., Hampton, R. A., & Halsey, N. A. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4624 · Cited by 12
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
Li, Y., Hermanson, D. L., Moriarity, B. S., & Kaufman, D. S. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.002 · Cited by 981
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
Self-citation
Metadata
- Authors
- Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2006-11-07
- Volume
- 214
- Issue
- 1
- Pages
- 73-91
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2059354338
- Cited by
- 650
- References
- 184
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.